Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/06/17
End: 12/30/17
Due: 12/30/18
Phase: N/A
Priority: Normal
Start: 11/30/20
End: 10/20/21
Due: 10/20/22
Phase: N/A
Priority: Normal
Start: 10/16/20
End: 10/30/21
Due: 10/30/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Bioavailability of ATI-1501 With Taste Test Sub Study | NCT03337126 | Appili Therapeutics Inc. | user2@example.com | None | 2017-11-06 | 2017-12-30 | 2018-12-30 | - | - | 2025-07-14 |
| The Prevent Severe COVID-19 (PRESECO) Study | NCT04600895 | Appili Therapeutics Inc. | user2@example.com | None | 2020-11-30 | 2021-10-20 | 2022-10-20 | - | - | 2025-07-14 |
| Control of COVID-19 Outbreaks in Long Term Care | NCT04448119 | Appili Therapeutics Inc. | user2@example.com | None | 2020-10-16 | 2021-10-30 | 2022-10-30 | - | - | 2025-07-14 |